CMP: 156

Alembic Pharmaceuticals Ltd. manufactures pharmaceuticals. The Company produces active pharmaceutical ingredients, bulk pharmaceutical chemicals, formulations, herbal nutraceuticals, and veterinary products.

Alembic Pharmaceuticals is a decent bet in mid-cap trading at a P/E of nearly 19 with dividend yields of nearly 1% in the last 12 months. It runs at a debt of 234 Crores with 4 Crores cash in hand. Revenues have risen from 1155 Crores to 1489 Crores in the last 2 years. Profits have risen from 81 Crores to 158 Crores in the last 2 years. Profit margins have risen from 7% to nearly 11% in the last 2 years. Buy and hold for long term gains.